WallStreetZen

NYSE: NVS
Novartis Ag Earnings & Revenue

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
24.38%
Industry
21.06%
Market
103.02%
NVS's earnings have grown slower (6.83% per year) than the US Drug Manufacturers - General industry average (16.78%)
Performance
NVS's earnings have grown slower (6.83% per year) than the US market average (30.18%)
Performance
NVS's earnings growth is accelerating - its growth over the last year (24.38%) is above its 5-year compound annual rate (6.83%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
4.09%
Industry
18.45%
Market
46.25%
NVS's revenue has grown slower (0.7% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
NVS's revenue has grown slower (0.7% per year) than the US market average (19.19%)
Performance
NVS's revenue growth is accelerating - its growth over the last year (4.09%) is above its 5-year compound annual rate (0.7%)
Performance

NVS earnings and revenue history

Current Revenue
$51.6B
Current Earnings
$9.0B
Current Profit Margin
17.4%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (-6.79%)
Performance

NVS Return on equity

Current Company
16.7%
Current Industry
33.2%
Current Market
32.8%
NVS's Return on Equity (16.7%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
7.1%
Current Industry
7.3%
Current Market
7.7%
NVS is generating lower Return on Assets (7.1%) than the US Drug Manufacturers - General industry average (7.54%)
Performance

NVS Return on capital employed

Current Company
12.44%
Current Industry
11.7%
NVS's ability to generate Return on Capital (12.44%) has decreased compared to 3 years ago (14.44%)
Performance

Novartis Ag Earnings & Revenue FAQ

What were NVS's earnings last quarter?

Novartis Ag (NYSE: NVS) reported Q2 2021 earnings per share (EPS) of $1.29, up 57.32% year over year. Total Novartis Ag earnings for the quarter were $2.90 billion. In the same quarter last year, Novartis Ag's earnings per share (EPS) was $0.82.

What was NVS's earnings growth in the past year?

As of Q3 2021, Novartis Ag's earnings has grown 24.38% year over year. This is 3.31 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 21.06%. Novartis Ag's earnings in the past year totalled $8.98 billion.

What was NVS's revenue last quarter?

Novartis Ag (NYSE: NVS) reported Q2 2021 revenue of $13.29 billion up 14.39% year over year. In the same quarter last year, Novartis Ag's revenue was $11.62 billion.

What was NVS's revenue growth in the past year?

As of Q3 2021, Novartis Ag's revenue has grown 4.09% year over year. This is 14.36 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 18.45%. Novartis Ag's revenue in the past year totalled $51.56 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.